Risk of Stroke Skyrockets With COVID-19 Infection After Vaccination

Perspectives on Health

Because the COVID-19 vaccines imbue the body with the genetic code for the thrombogenic and lethal Wuhan spike protein, those who receive one of the shots are vulnerable to a disaster if they become infected with SARS-CoV-2 after receiving one of the shots.

Emory University researchers Nahab et al. examined a statewide database of COVID-19 vaccine recipients. Between December 2020 and March 2022, approximately 5 million adult Georgians received at least one COVID-19 vaccine: 54% received BNT162b2 (Pfizer), 41% received mRNA-1273 (Moderna), and 5% received Ad26.COV2.S (Johnson & Johnson). Those who had concurrent COVID-19 infection within 21 days of vaccination had a higher risk of ischemic (OR = 8.00, 95% CI: 4.18, 15.31) and hemorrhagic stroke (OR = 5.23, 95% CI: 1.11, 24.64).
This analysis demonstrates one of many significant risks associated with rapid vaccine development and rollout in the absence of adequate data safety and monitoring. Stroke is a devastating outcome, and it appears that a large number of debilitating cases could have been avoided if the COVID-19 vaccines were withdrawn from the market for excess mortality in January 2021. This study’s patients would have avoided stroke and disability.

These findings highlight the need for spike protein detoxification, or methods to reduce spike protein burden in the body. We have a highly anticipated manuscript in press that features an ambulatory triple combination regimen of nattokinase, bromelain, and curcumin that works proteolytically to clear spike protein while providing low-level thrombolysis and inflammation control.

Reposted from Substack by Peter McCullough. The McCullough Foundation helped fund this project in part.